Simon M Barratt-Boyes

Simon M Barratt-Boyes is a Professor and PhD Program Director in the Department of Infectious Diseases and Microbiology at the University of Pittsburgh, with research spanning viral pathogenesis, immunology, and pandemic countermeasures development.

• 1984: Bachelor of Veterinary Science, Massey University, Palmerston North, New Zealand
• 1988: Large animal medicine residency, University of California Veterinary Medical Teaching Hospital
• 1991: Diplomate Large Animal Medicine, American College of Veterinary Internal Medicine
• 1993: PhD in comparative pathology, University of California, Davis
• 1997: Postdoctoral fellow in tumor immunology, University of Pittsburgh

His research integrates virology and immunology to address critical gaps in understanding host-pathogen interactions. Key contributions include developing the first translational nonhuman primate model for severe H5N1 influenza that replicates human pathology, and pioneering human skin explant models demonstrating how genetic ancestry dictates inflammatory responses to dengue virus. His work reveals why African ancestry confers protection against severe dengue through attenuated inflammation, while European ancestry promotes viral replication via hyperinflammation.

Analysis of his 2022-2025 publications shows consistent focus on emerging viral threats (influenza, dengue, SARS-CoV-2) using advanced models. Research themes include host genetic factors in infection outcomes, medical countermeasure evaluation (antibodies/vaccines), and pathogenesis mechanisms. His interdisciplinary approach bridges virology, immunology, and genetics to solve persistent public health challenges.

As PhD Program Director, Barratt-Boyes oversees graduate training while leading collaborative projects with NIH and International Center for Medical Research in Uganda (IDM). Although specific grants aren't detailed, his high-impact publications in Science and Nature Communications indicate substantial extramural funding for pandemic preparedness research.

His laboratory team employs nonhuman primate and human skin models to investigate viral pathogenesis, with recent work focusing on aerosolized influenza transmission, dengue-virus ancestry interactions, and SARS-CoV-2 variant neutralization. Collaborations span virology, immunology, and genomics disciplines across multiple institutions.